J.Safra Asset Management Corp
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1535293
NEW YORK, NY
Position in TEVA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$650,631
-$93,363 QoQ
Shares Held
19,204
-22.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#372
of 671 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026J.Safra Asset Management Corp holds $752,734 across 7 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (86.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
19,204 | $650,631 | |
| 2 | ZTS |
Zoetis Inc.
|
685 | $49,224 | |
| 3 | VTRS |
Viatris Inc
|
1,247 | $19,802 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
128 | $14,200 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
134 | $8,569 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
315 | $5,657 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
189 | $4,651 |
All Filings in TEVA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $650,631 | 19,204 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $743,994 | 24,701 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $790,362 | 25,324 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $314,817 | 15,585 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $260,651 | 15,552 | Shares | Sole | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||